Home-based Pulmonary Rehabilitation with Remote Monitoring in Pulmonary Arterial Hypertension

Overview

About this study

The aim of this study is to evaluate the effects of a home-based program with health coaching of dyspnea and exercieses in subjects with pulmonary arterial hypertension (PAH).

Pulmonary rehabiltation has been shown to be an effective treatment for patients with chronic obstructive pulmonary disease, however there is currently a paucity of evidence to extrapolate this informaiton with patients with pulmonary arterial hypertension (PAH). In addition, there are no options outside of center-based pulmonary rehabilitation which have been proposed as an effective treatment option for patients with PAH.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Diagnosis of PAH, confirmed by right heart catheterization (mean pulmonary artery pressure of 20 mmHg or greater, pulmonary vascular resistance of 3.0 Woods units or greater, Pulmonary capillary wedge pressure of 15 mmHg or lower).
Age ≥ 18 years.
On PAH-specific therapy which is at stable dosing (i.e., not currently titrating therapy).
NYHA class II-III symptoms.
able to complete a six-minute walk test.

Exclusion Criteria:

Patients experiencing syncope or exertional syncope.
Patients not experiencing exertional dyspnea.
Inability to walk.
Patients currently in pulmonary rehab or having completed pulmonary rehab within three months (unlikely to improve).

Eligibility last updated 3/14/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Hilary DuBrock, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Johanna Hoult M.A. (507) 293-1989 Hoult.Johanna@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Hilary DuBrock, M.D.

Closed-enrolling by invitation

Contact information:

Johanna Hoult M.A.

(507) 293-1989

Hoult.Johanna@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials